CapMan Life Science invests in Swereco
CapMan has invested in Swereco AB through its CapMan Life Science IV fund.
The company produces ergonomic products primarily designed for the physically challenged. CapMan's investment will support an acceleration of the company's expansion and a strengthening of the existing business model.
Swereco was founded in 1973 and recorded net sales of approximately €5.5m in 2009. CapMan will together with Svenskt Företagskapital be the main owners of the company.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Viktor Lundvall on +44 20 7004 7476 or viktor.lundvall@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








